Mitochondrial Approaches to Protect Against Cardiac Ischemia and Reperfusion Injury
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The mitochondrion is a vital component in cellular energy metabolism and intracellular signaling processes. Mitochondria are involved in a myriad of complex signaling cascades regulating cell death vs. survival. Importantly, mitochondrial dysfunction and the resulting oxidative and nitrosative stress are central in the pathogenesis of numerous human maladies including cardiovascular diseases, neurodegenerative diseases, diabetes, and retinal diseases, many of which are related. This review will examine the emerging understanding of the role of mitochondria in the etiology and progression of cardiovascular diseases and will explore potential therapeutic benefits of targeting the organelle in attenuating the disease process. Indeed, recent advances in mitochondrial biology have led to selective targeting of drugs designed to modulate or manipulate mitochondrial function, to the use of light therapy directed to the mitochondrial function, and to modification of the mitochondrial genome for potential therapeutic benefit. The approach to rationally treat mitochondrial dysfunction could lead to more effective interventions in cardiovascular diseases that to date have remained elusive. The central premise of this review is that if mitochondrial abnormalities contribute to the etiology of cardiovascular diseases (e.g., ischemic heart disease), alleviating the mitochondrial dysfunction will contribute to mitigating the severity or progression of the disease. To this end, this review will provide an overview of our current understanding of mitochondria function in cardiovascular diseases as well as the potential role for targeting mitochondria with potential drugs or other interventions that lead to protection against cell injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 2×
“Therefore, these thiol-reducing agents are critically involved in defense against large increases in O2 − emission (Sen, 1998; Ueda et al., 1998; Lin and Beal, 2006; Stowe and Camara, 2009).”
BackgroundRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 3×
“…2002) but recently also to heart cells and trabeculae under working conditions (Cortassa et al., 2009). cardIac MetabolIc control – hIstorIcal PersPectIve Randle et al. (1963) long ago first recognized that cells utilize either FA or glucose depending on substrate availability and that the…”
BackgroundMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 1×
“Specifically, PBR interacts with mPTP through VDAC and regulates apoptosis as it blocks the anti-apoptotic effect of Bcl-2 family proteins (Kroemer et al., 2007).”
BackgroundCalcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575 · cited 3×
“In fact, this unique attribute of mitochondria has been employed to direct the so-called “mitochondriotropic” drugs to target the matrix (Brookes et al., 2004).”
BackgroundBaines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W., et al. (2005) · Nature · doi:10.1038/nature03434 · Cited by 2,280
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Mitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial Fusion
Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G. V., Rudka, T., Bartoli, D., Polishuck, R. S., Danial, N. N., De Strooper, B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.025 · Cited by 1,673 · cited 1×
“IMM proteases, by targeting mitochondrial fusion proteins (discussed below), also regulate the release of cytochrome c release from mitochondria (Frezza et al., 2006).”
Production of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
Reactive Oxygen Species (Ros-Induced) Ros Release
Zorov, D. B., Filburn, C. R., Klotz, L.-O., Zweier, J. L., & Sollott, S. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1001 · Cited by 1,412
Role of calcium ions in regulation of mammalian intramitochondrial metabolism
McCormack, J. G., Halestrap, A. P., & Denton, R. M. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.391 · Cited by 1,398 · cited 2×
“Oxidative damage to mitochondrial membranes, enzymes, and electron transport chain Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury”
BackgroundMitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission.
Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., & Mihara, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607279200 · Cited by 1,226 · cited 1×
“In cells derived from disease states, the compromise in ∆Ψ m is a consequence of defects in ETC com- plexes (McBride et al., 2006; Taguchi et al., 2007).”
BackgroundUbisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
Turrens, J. F., Alexandre, A., & Lehninger, A. L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90293-0 · Cited by 1,214 · cited 2×
“However, the specific sites and mechanisms of O2 − generation remain unsettled (Turrens et al., 1985; Ambrosio et al., 1993; Babcock and Varotsis, 1993; Chen et al., 2003).”
BackgroundBax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168 · cited 1×
“ANT interacts with both the anti-apoptotic and pro-apoptotic BCl-2 protein families, which then act as allosteric modulators of the ATP/ADP anti-porter (Marzo et al., 1998; Brenner et al., 2000; Belzacq et al., 2003).”
BackgroundCadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855 · cited 24×
“The hypothesis that ATP, ADP, CrP, and P i are not the primary feedback regulators of OxPhos, e.g., during an increase in workload and O 2 consumption, is based on numerous data that the concentrations of these compounds do not change significantly (Neely et al., 1972; Raymond and Potreau, 1977; Katz et al., 1989; Bal…”
BackgroundInfluentialProperties of the Permeability Transition Pore in Mitochondria Devoid of Cyclophilin D
Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A., & Bernardi, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500089200 · Cited by 808 · cited 1×
“…of CypD in the regulation of cell survival or death is evidenced by the finding that cells lacking the Ppif gene that encodes the protein are protected from necrotic caspase-independent cell death, but not from caspase-dependent apoptosis (Kim et al., 2003; Baines et al., 2005; Basso et al., 2005).”
BackgroundMetabolic control analysis: a survey of its theoretical and experimental development
Fell, D. A. (1992) · Biochemical Journal · doi:10.1042/bj2860313 · Cited by 782 · cited 1×
“Metabolic Control Analysis is a methodology that allows one to quantitate the control of flux and metabolites through a metabolic pathway (Kacser and Burns, 1973; Heinrich and Rapoport, 1974; Fell, 1992).”
MethodDoughan, A. K., Harrison, D. G., & Dikalov, S. I. (2008) · Circulation Research · doi:10.1161/circresaha.107.162800 · Cited by 710
Di Lisa, F., Menabò, R., Canton, M., Barile, M., & Bernardi, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006825200 · Cited by 678 · cited 1×
“But irreversible opening of the pore leads to release of apoptotic protein factors (Kim et al., 2003; Martinez-Ruiz et al., 2008; Sun et al., 2008), and a loss of NAD+ results in impaired capacity to restore redox signaling and O2 − scavenging (Di Lisa et al., 2001).”
BackgroundNADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630 · cited 8×
“Increased vessel wall Nox-derived O2 − is indeed an important determinant of endothelial dysfunction in experimental angiotensin II (AII)-induced hypertension and genetic hypertension (Cave et al., 2006).”
BackgroundResultInfluentialA signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling
Echtay, K. S., Esteves, T. C., Pakay, J. L., Jekabsons, M. B., Lambert, A. J., Portero‐Otín, M., Pamplona, R., Vidal‐Puig, A. J., Wang, S., Roebuck, S. J., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg412 · Cited by 597
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I
Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1052 · Cited by 521
Aon, M. A., Cortassa, S., Marbán, E., & O'Rourke, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302673200 · Cited by 521
Regulation of energy substrate metabolism in the diabetic heart
Stanley, W. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00047-3 · Cited by 480 · cited 2×
“Other drugs such as trimetazidine, which blocks the key enzyme in FA oxidation, as well as ranolazine, are reported to directly attenuate β-oxidation enzyme activity and potentially other metabolic enzymes (Stanley et al., 1997; Bristow, 2000).”
BackgroundStowe, D. F., & Camara, A. K. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2331 · Cited by 471
Self-citationParadies, G., Petrosillo, G., Pistolese, M., Di Venosa, N., Federici, A., & Ruggiero, F. M. (2004) · Circulation Research · doi:10.1161/01.res.0000109416.56608.64 · Cited by 468
Selective targeting of an antioxidant to mitochondria
Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466
Mitochondrial H + Leak and ROS Generation: An Odd Couple
Brookes, P. S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.016 · Cited by 447
Regulation of oxidative phosphorylation in the mammalian cell
Balaban, R. S. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.258.3.c377 · Cited by 446 · cited 2×
“Oxidative damage to mitochondrial membranes, enzymes, and electron transport chain Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury”
BackgroundCalvert, J. W., Gundewar, S., Jha, S., Greer, J. J. M., Bestermann, W. H., Tian, R., & Lefer, D. J. (2008) · Diabetes · doi:10.2337/db07-1098 · Cited by 422
Hendgen-Cotta, U. B., Merx, M. W., Shiva, S., Schmitz, J., Becher, S., Klare, J. P., Steinhoff, H.-J., Goedecke, A., Schrader, J., Gladwin, M. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801336105 · Cited by 418 · cited 1×
“As noted above, an inhibitory effect of NO on ETC, particularly complexes I and IV, has been suggested to increase cellular viability in myocardial I/R injury by decreasing ROS generation during reperfusion (Hendgen-Cotta et al., 2008).”
BackgroundMammalian Mitochondrial Complex I: Biogenesis, Regulation, and Reactive Oxygen Species Generation
Koopman, W. J. H., Nijtmans, L. G. J., Dieteren, C. E. J., Roestenberg, P., Valsecchi, F., Smeitink, J. A. M., & Willems, P. H. G. M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2743 · Cited by 411
AZOULAY-ZOHAR, H., ISRAELSON, A., ABU-HAMAD, S., & SHOSHAN-BARMATZ, V. (2004) · Biochemical Journal · doi:10.1042/bj20031465 · Cited by 408 · cited 1×
“For example, it was reported that closure of VDAC by HK prevents mPTP opening and blocks apoptosis (Azoulay-Zohar et al., 2004).”
BackgroundThe role of mitochondria in protection of the heart by preconditioning
Halestrap, A. P., Clarke, S. J., & Khaliulin, I. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.05.008 · Cited by 390 · cited 1×
“Adenine nucleotides, Mg2+, and matrix H+ restrict the pore from opening (Brookes et al., 2004; Duchen, 2004; Halestrap et al., 2004, 2007; O’Rourke, 2007).”
BackgroundEndothelial Mitochondria: Contributing to Vascular Function and Disease
Davidson, S. M., & Duchen, M. R. (2007) · Circulation Research · doi:10.1161/01.res.0000261970.18328.1d · Cited by 381 · cited 8×
“In addition, endothelial cell mCa2+ overload, diminished levels of MnSOD activity, and decreases in ETC complex activities, have all been implicated in the events that lead to endothelial and vascular cell injury and death (Pipinos et al., 2006; Davidson and Duchen, 2007).”
BackgroundInfluentialJames, A. M., Cochemé, H. M., Smith, R. A. J., & Murphy, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501527200 · Cited by 353
Mitochondrial reactive oxygen species and Ca 2+ signaling
Camello-Almaraz, C., Gomez-Pinilla, P. J., Pozo, M. J., & Camello, P. J. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00217.2006 · Cited by 336
Zuckerbraun, B. S., Chin, B. Y., Bilban, M., d'Avila, J. D. C., Rao, J., Billiar, T. R., & Otterbein, L. E. (2007) · The FASEB Journal · doi:10.1096/fj.06-6644com · Cited by 323 · cited 2×
“CO, like NO and H 2 S, reversibly binds to the reduced complex IV where it competes with O 2 ; CO may block O 2 binding at complex IV in vivo (Zuckerbraun et al., 2007) and lead to cardioprotection against I/R injury, whereas Na azide, a cyanide containing compound which also inhibits complex IV, was found to be inef…”
BackgroundKATP channel‐independent targets of diazoxide and 5‐hydroxydecanoate in the heart
Hanley, P. J., Mickel, M., Löffler, M., Brandt, U., & Daut, J. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.023960 · Cited by 320 · cited 2×
“For example, Hanley et al. (Hanley et al., 2002, 2003; Hanley and Daut, 2005) reported that the putative mitoK ATP channel opener diazoxide may protect against I/R injury in part by inhibiting complex II, which could lead to less e− transfer to complex III and decrease reverse e− flow to complex I, and in the process…”
BackgroundUncoupling Protein-2 Overexpression Inhibits Mitochondrial Death Pathway in Cardiomyocytes
Teshima, Y., Akao, M., Jones, S. P., & Marbán, E. (2003) · Circulation Research · doi:10.1161/01.res.0000085581.60197.4d · Cited by 318 · cited 4×
“However, high m[Ca2+], as observed during cardiac I/R, can impair ATP synthesis and lead to a loss of ion homeostasis, stimulation of ROS generation, mPTP opening, matrix swelling, and OMM rupture (Jones et al., 2003; Teshima et al., 2003b).”
BackgroundInfluentialChen, Q., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00211.2007 · Cited by 299
The functional nitrite reductase activity of the heme-globins
Gladwin, M. T., & Kim-Shapiro, D. B. (2008) · Blood · doi:10.1182/blood-2008-01-115261 · Cited by 293 · cited 4×
“Although NOS produces the bulk of NO, there is increasing interest in NOS independent generation of NO in vivo, particularly during hypoxia or anoxia, where low O 2 tensions limit NOS activity and when the nitrite reductase activity of myoglobin and hemoglobin are highest (Gladwin and Kim-Shapiro, 2008).”
BackgroundInfluentialKevin, L. G., Camara, A. K. S., Riess, M. L., Novalija, E., & Stowe, D. F. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00711.2002 · Cited by 272
Self-citationChen, Q., Camara, A. K. S., Stowe, D. F., Hoppel, C. L., & Lesnefsky, E. J. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00270.2006 · Cited by 271
Self-citationHANLEY, P., & DAUT, J. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.04.002 · Cited by 218 · cited 2×
“(Hanley et al., 2002, 2003; Hanley and Daut, 2005) reported that the putative mitoK ATP channel opener diazoxide may protect against I/R injury in part by inhibiting complex II, which could lead to less e− transfer to complex III and decrease reverse e− flow to complex I, and in the process minimize O2 − generation.”
BackgroundLu, Z., Xu, X., Hu, X., Fassett, J., Zhu, G., Tao, Y., Li, J., Huang, Y., Zhang, P., Zhao, B., et al. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2940 · Cited by 215 · cited 1×
“Furthermore, treatment with the MnSOD mimetic MnTMPyP significantly reduced the transverse aortic constriction-induced left ventricular hypertrophy and dysfunction in PGC-1α−/− deficient mice (Lu et al., 2010).”
BackgroundChen, Q., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110262 · Cited by 215
Mitochondrial regular arrangement in muscle cells: a “crystal-like” pattern
Vendelin, M., Béraud, N., Guerrero, K., Andrienko, T., Kuznetsov, A. V., Olivares, J., Kay, L., & Saks, V. A. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00281.2004 · Cited by 193 · cited 2×
“(2003, 2006b), and a several other investigators (Zorov et al., 2000, 2004; Vendelin et al., 2005), have reported that fusion and fission are neither required for normal mitochondrial function in cardiomyocytes, nor in all cell types.”
BackgroundMitochondrial proton leak and the uncoupling protein 1 homologues
Stuart, J. A., Cadenas, S., Jekabsons, M. B., Roussel, D., & Brand, M. D. (2001) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00243-7 · Cited by 169 · cited 1×
“There are four UCPs variants (1–4) believed to induce inward H+ leak in energized mitochondria (Jezek et al., 1998; Stuart et al., 2001; Brookes, 2005; Stowe and Camara, 2009) (Figure 1) and thereby to uncouple OxPhos.”
BackgroundCardioprotection by metabolic shut-down and gradual wake-up
Burwell, L. S., Nadtochiy, S. M., & Brookes, P. S. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.026 · Cited by 146
Effect of Cytochrome c on the Generation and Elimination of O2⨪ and H2O2 in Mitochondria
Zhao, Y., Wang, Z.-B., & Xu, J.-X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209681200 · Cited by 129 · cited 4×
“In I/R injury, loss of cytochrome c through mPTP or OMM permeabilization, as a result of oxidative damage to cardiolipin and membrane proteins, inhibits or slows down respiration, which leads to increased e− leak (Zhao et al., 2003; Li et al., 2006); the outcome is a vicious cycle of more O2 − production and more cel…”
BackgroundInfluentialRiess, M. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.016 · Cited by 118 · cited 1×
“…now show that increases in mitochondrial ROS and m[Ca2+] occur nearly simultaneously during ischemia (Vanden Hoek et al., 1997; Kevin et al., 2003; Riess et al., 2004; Stowe et al., 2006; Camara et al., 2007; Aldakkak et al., 2008a,b) and that their reduction on reperfusion are indicative of…”
BackgroundWojtovich, A. P., & Brookes, P. S. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0001-y · Cited by 107 · cited 2×
“The authors observed that although atpenin interacts with complex II, it had no direct effect to decrease complex II activity and that it is indeed a potent mitoK ATP channel activator (Wojtovich and Brookes, 2009).”
BackgroundDevelopment of Mitochondria‐targeted Aromatic‐cationic Peptides for Neurodegenerative Diseases
Szeto, H. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.013 · Cited by 100 · cited 1×
“For example, SS-31, which scavenges matrix H 2 O 2 and ONOO−, reduced cytochrome c release and minimized mitochondrial swelling; its efficacy has been demonstrated in vivo by its effect to reduce cardiac and brain I/R injury in animal models (Cho et al., 2007; Thomas et al., 2007; Szeto, 2008a,b).”
BackgroundNortriptyline Protects Mitochondria and Reduces Cerebral Ischemia/Hypoxia Injury
Zhang, W.-H., Wang, H., Wang, X., Narayanan, M. V., Stavrovskaya, I. G., Kristal, B. S., & Friedlander, R. M. (2008) · Stroke · doi:10.1161/strokeaha.107.496810 · Cited by 80
Zoccarato, F., Cavallini, L., Bortolami, S., & Alexandre, A. (2007) · Biochemical Journal · doi:10.1042/bj20070215 · Cited by 66 · cited 1×
“When FADH 2 related substrates are used and an e− enters the ETC at complex II, O2 − may be generated by reverse e− transfer to the FMN site of complex I (Chen et al., 2007; Zoccarato et al., 2007; Stowe and Camara, 2009).”
BackgroundCamara, A. K. S., Aldakkak, M., Heisner, J. S., Rhodes, S. S., Riess, M. L., An, J., Heinen, A., & Stowe, D. F. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00231.2006 · Cited by 42
Self-citation
Cited by
Mitochondrial ROS in myocardial ischemia reperfusion and remodeling
Bugger, H., & Pfeil, K. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165768 · Cited by 460
Effects of Exercise to Improve Cardiovascular Health
Pinckard, K., Baskin, K. K., & Stanford, K. I. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00069 · Cited by 446
Figueira, T. R., Barros, M. H., Camargo, A. A., Castilho, R. F., Ferreira, J. C. B., Kowaltowski, A. J., Sluse, F. E., Souza-Pinto, N. C., & Vercesi, A. E. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4729 · Cited by 419
Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394
Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target
Camara, A. K. S., Zhou, Y., Wen, P.-C., Tajkhorshid, E., & Kwok, W.-M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00460 · Cited by 352
Self-citation
Metadata
- Authors
- Camara, A. K. S., Bienengraeber, M., & Stowe, D. F.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2011
- Volume
- 2
- Pages
- 13-13
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W2160595902
- Cited by
- 151
- References
- 57
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.